IBJNews

2011 Health Care Heroes: George W. Sledge Jr., MD

Back to TopCommentsE-mailPrintBookmark and Share

Health Care HeroesWINNER: Advancements in Health Care

George W. Sledge Jr., MD

Ballve-Lantero Professor of Oncology, Professor of Medicine and Pathology, Indiana University Melvin and Bren Simon Cancer Center

 

sledge-george (IBJ Photo/ Perry Reichanadter)

If you ask George Sledge why he became an oncologist, he doesn’t hesitate. He can tell you exactly when he knew that’s what he wanted to do. While an intern at St. Louis University, he had to inform a young mother that she had leukemia. “I’ll always remember what Carmelita asked me,” Sledge said. “She asked, ‘Who will take care of my children?’” That had a huge emotional impact on me.”

After completing his residency, Sledge, 59, went on to complete an oncology fellowship at the University of Texas in San Antonio, studying for several years under nationally known breast cancer researcher Bill McGuire.

When Sledge came to IU in 1983, he was the only oncologist with expertise in the area of breast cancer, and it was under his leadership that IU opened its first breast clinic.

That’s where he’s made his mark in medical research, developing life enhancing treatments and cancer-care protocols that have improved the care and outcomes of breast cancer patients.

One area of research Sledge is involved with is biologic treatments for breast cancer, especially anti-angiogenic therapies, such as the drug Avastin. Anti-angiogenic therapies prevent the development of new blood vessels or stunt new blood vessel growth in cancer cells, consequently starving them. Sledge also conducted studies involving the drug Herceptin, used in conjunction with chemotherapy to help prolong the lives of patients with metastatic HER2+ breast cancer.

Perhaps Sledge’s most far-reaching contribution to breast cancer research was with Taxol, a chemotherapy treatment. He led the first major trial in the use of Taxol as a treatment for breast cancer. The Phase III trial lasted from 1993 to 1997, with institutions nationwide participating. As a result, Taxol is now commonly used by many breast cancer patients. The findings from this trial also demonstrated that sequential use of chemotherapies, which is much less toxic and easier for patients to tolerate, was just as beneficial as using chemotherapies in tandem.

“Drugs like Avastin, Herceptin and Taxol are valuable to the extent that they prolong women’s lives, first and foremost,” Sledge said. “So my career as a breast cancer researcher has been designed in large part to try and develop new agents that will prolong women’s lives, and hopefully, when applied to women with early-stage breast cancer, increase their cure rate.”

As co-director of IU’s Breast Cancer Program, Sledge leads a breast cancer research team of more than 30 members. The program has produced several patents and two startup companies and is involved in more than 70 clinical trials. Its annual research grant funding now exceeds $11 million, and it received a $20 million gift from the Vera Bradley Foundation for Breast Cancer Research.

“During the most recent review from the National Cancer Institute, the Breast Cancer research program at the IU Simon Cancer Center earned one of the National Cancer Institute’s highest rankings,” said Patrick Loehrer Sr., director of the IU Simon Cancer Center. “This doesn’t just happen by chance. It is a result of the hard work of George and his many colleagues from numerous disciplines. Together, they continue to make a mark worldwide by improving the prognosis of breast cancer and increasing not only the duration of life, but also the quality of life for women with this disease.”

Over the years Sledge has received several prestigious national awards, such as the 2010 William L. McGuire Memorial Lecture Award at the San Antonio Breast Cancer Symposium, the 2007 Rose Award from the Breast Cancer Research Foundation and the 2006 Brinker Award from the Komen Foundation.

Sledge has also provided leadership for numerous organizations, including the FDA’s Oncology Drug Advisory Committee, Hoosier Oncology Group, the Eastern Cooperative Oncology Group’s Breast Cancer Committee and the Department of Defense Oncology Drug Advisory Committee. He currently serves as president of the American Society of Clinical Oncology.

While awards and recognition are nice, Sledge considers his greatest achievement being able to help his patients, and the beast cancer program is the vehicle that allows him to do it.

“Like most doctors, what drives me when I get up in the morning and what keeps me going during a very long day is my ability to help my patients,” Sledge said. “I hope to continue to help the women of central Indiana live better lives through the application of cutting-edge research so they will have a chance to be first in line for new therapies, new drugs and new developments that will prolong their lives and minimize or eliminate their suffering.”

After all these years, he’s still trying to ensure the “Carmelitas” under his care will live to raise their children.

“In the breast cancer research world, George Sledge is a rock star,” Loehrer said. “But he goes about his work in a down-to-earth manner, whether he’s talking with a patient, teaching younger scientists or doing an interview with the national media. To us at the IU Simon Cancer Center and to his patients, George is a true hero.”•

____

Click here to return to the Health Care Heroes landing page.

ADVERTISEMENT

  • Herceptin
    Thank you for all you are doing for Stage IV. It is NOT just women anymore lets not forget that. Also, Herceptin does not work for someone like me Her2-. So where do we go from here?

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
thisissue1-092914.jpg 092914

Subscribe to IBJ
  1. Cramer agrees...says don't buy it and sell it if you own it! Their "pay to play" cost is this issue. As long as they charge customers, they never will attain the critical mass needed to be a successful on company...Jim Cramer quote.

  2. My responses to some of the comments would include the following: 1. Our offer which included the forgiveness of debt (this is an immediate forgiveness and is not "spread over many years")represents debt that due to a reduction of interest rates in the economy arguably represents consideration together with the cash component of our offer that exceeds the $2.1 million apparently offered by another party. 2. The previous $2.1 million cash offer that was turned down by the CRC would have netted the CRC substantially less than $2.1 million. As a result even in hindsight the CRC was wise in turning down that offer. 3. With regard to "concerned Carmelite's" discussion of the previous financing Pedcor gave up $16.5 million in City debt in addition to the conveyance of the garage (appraised at $13 million)in exchange for the $22.5 million cash and debt obligations. The local media never discussed the $16.5 million in debt that we gave up which would show that we gave $29.5 million in value for the $23.5 million. 4.Pedcor would have been much happier if Brian was still operating his Deli and only made this offer as we believe that we can redevelop the building into something that will be better for the City and City Center where both Pedcor the citizens of Carmel have a large investment. Bruce Cordingley, President, Pedcor

  3. I've been looking for news on Corner Bakery, too, but there doesn't seem to be any info out there. I prefer them over Panera and Paradise so can't wait to see where they'll be!

  4. WGN actually is two channels: 1. WGN Chicago, seen only in Chicago (and parts of Canada) - this station is one of the flagship CW affiliates. 2. WGN America - a nationwide cable channel that doesn't carry any CW programming, and doesn't have local affiliates. (In addition, as WGN is owned by Tribune, just like WTTV, WTTK, and WXIN, I can't imagine they would do anything to help WISH.) In Indianapolis, CW programming is already seen on WTTV 4 and WTTK 29, and when CBS takes over those stations' main channels, the CW will move to a sub channel, such as 4.2 or 4.3 and 29.2 or 29.3. TBS is only a cable channel these days and does not affiliate with local stations. WISH could move the MyNetwork affiliation from WNDY 23 to WISH 8, but I am beginning to think they may prefer to put together their own lineup of syndicated programming instead. While much of it would be "reruns" from broadcast or cable, that's pretty much what the MyNetwork does these days anyway. So since WISH has the choice, they may want to customize their lineup by choosing programs that they feel will garner better ratings in this market.

  5. The Pedcor debt is from the CRC paying ~$23M for the Pedcor's parking garage at City Center that is apprased at $13M. Why did we pay over the top money for a private businesses parking? What did we get out of it? Pedcor got free parking for their apartment and business tenants. Pedcor now gets another building for free that taxpayers have ~$3M tied up in. This is NOT a win win for taxpayers. It is just a win for Pedcor who contributes heavily to the Friends of Jim Brainard. The campaign reports are on the Hamilton County website. http://www2.hamiltoncounty.in.gov/publicdocs/Campaign%20Finance%20Images/defaultfiles.asp?ARG1=Campaign Finance Images&ARG2=/Brainard, Jim

ADVERTISEMENT